Generation Bio (GBIO) PT Lowered to $27 at Needham & Company
Tweet Send to a Friend
Needham & Company analyst Gil Blum lowered the price target on Generation Bio (NASDAQ: GBIO) to $27.00 (from $50.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
